ReviewLife (Basel, Switzerland)2021

Molecular Targets for Biological Therapies of Severe Asthma: Focus on Benralizumab and Tezepelumab.

Shih-Lung ChengPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.